ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002